Allan Thomas Højland

4PUBLICATIONS
18CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedNeurogeneticsOther European languagesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 19, 2021
A wide range of protective and predisposing variants in aggrecan influence the susceptibility for otosclerosis.

Allan Thomas Højland, Lisse J M Tavernier, Isabelle Schrauwen

|Mar 05, 2021
First reported CABP2-related non-syndromic hearing loss in Northern Europe.

Inger Norlyk Sheyanth, Allan Thomas Højland, Henrik Okkels

|Nov 22, 2018
First reported adult patient with TARP syndrome: A case report.

Allan T Højland, Ihab Lolas, Henrik Okkels

Pageof 1